155 related articles for article (PubMed ID: 7617735)
21. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.
Guiard BP; El Mansari M; Merali Z; Blier P
Int J Neuropsychopharmacol; 2008 Aug; 11(5):625-39. PubMed ID: 18205979
[TBL] [Abstract][Full Text] [Related]
22. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
[TBL] [Abstract][Full Text] [Related]
23. Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats.
Muñoz A; Lopez-Real A; Labandeira-Garcia JL; Guerra MJ
Exp Brain Res; 2003 Nov; 153(1):92-9. PubMed ID: 12955385
[TBL] [Abstract][Full Text] [Related]
24. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
Minnema DJ; Rosecrans JA
Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
[TBL] [Abstract][Full Text] [Related]
25. Effects on spontaneous and cocaine-induced behavior of pharmacological inhibition of noradrenergic and serotonergic systems.
Carey RJ; DePalma G; Shanahan A; Damianopoulos EN; Müller CP; Huston JP
Pharmacol Biochem Behav; 2008 Mar; 89(1):54-63. PubMed ID: 18155756
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of neuroleptic and serotonergic drugs on amphetamine-induced hypothermia in mice.
Boschi G; Launay N
Neuropharmacology; 1985 Feb; 24(2):117-22. PubMed ID: 2859540
[TBL] [Abstract][Full Text] [Related]
27. Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment.
Bruto V; Beauchamp C; Zacharko RM; Anisman H
Psychopharmacology (Berl); 1984; 83(1):62-9. PubMed ID: 6429702
[TBL] [Abstract][Full Text] [Related]
28. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism.
Cooper BR; Wang CM; Cox RF; Norton R; Shea V; Ferris RM
Neuropsychopharmacology; 1994 Oct; 11(2):133-41. PubMed ID: 7840865
[TBL] [Abstract][Full Text] [Related]
29. Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood.
Labonte B; McLaughlin RJ; Dominguez-Lopez S; Bambico FR; Lucchino I; Ochoa-Sanchez R; Leyton M; Gobbi G
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1319-30. PubMed ID: 22053980
[TBL] [Abstract][Full Text] [Related]
30. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
Baker LE; Svensson KA; Garner KJ; Goodwin AK
Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258
[TBL] [Abstract][Full Text] [Related]
31. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems.
Bhat RV; Baraban JM
J Pharmacol Exp Ther; 1993 Oct; 267(1):496-505. PubMed ID: 8229780
[TBL] [Abstract][Full Text] [Related]
32. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
Kokkinidis L; Anisman H
Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
[TBL] [Abstract][Full Text] [Related]
33. A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys.
Kamien JB; Woolverton WL
J Pharmacol Exp Ther; 1989 Mar; 248(3):938-46. PubMed ID: 2649658
[TBL] [Abstract][Full Text] [Related]
34. Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain.
Chernoloz O; El Mansari M; Blier P
Neuropsychopharmacology; 2009 Feb; 34(3):651-61. PubMed ID: 18688211
[TBL] [Abstract][Full Text] [Related]
35. Noradrenergic terminals are the primary source of α
Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
[TBL] [Abstract][Full Text] [Related]
36. Host brain regulation of dopaminergic grafts function: role of the serotonergic and noradrenergic systems in amphetamine-induced responses.
Muñoz A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
Synapse; 2003 Jan; 47(1):66-76. PubMed ID: 12422375
[TBL] [Abstract][Full Text] [Related]
37. Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination.
Goodwin AK; Pynnonen DM; Baker LE
Pharmacol Biochem Behav; 2003 Mar; 74(4):987-95. PubMed ID: 12667914
[TBL] [Abstract][Full Text] [Related]
38. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.
Raiteri M; Bertollini A; Angelini F; Levi G
Eur J Pharmacol; 1975 Nov; 34(1):189-95. PubMed ID: 1234761
[TBL] [Abstract][Full Text] [Related]
39. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.
Dukat M; Wesolowska A; Young R; Glennon RA
Pharmacol Biochem Behav; 2007; 87(2):203-7. PubMed ID: 17540440
[TBL] [Abstract][Full Text] [Related]
40. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex.
Gresch PJ; Sved AF; Zigmond MJ; Finlay JM
J Neurochem; 1995 Jul; 65(1):111-6. PubMed ID: 7790854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
